- Home
- SNY vs HASI Comparison
SNY vs HASI Comparison
Compare SNY & HASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNY
- HASI
- Stock Information
- Founded
- SNY 1994
- HASI 1981
- Country
- SNY France
- HASI United States
- Employees
- SNY N/A
- HASI N/A
- Industry
- SNY Biotechnology: Pharmaceutical Preparations
- HASI Real Estate Investment Trusts
- Sector
- SNY Health Care
- HASI Real Estate
- Exchange
- SNY Nasdaq
- HASI Nasdaq
- Market Cap
- SNY 116.5B
- HASI 3.4B
- IPO Year
- SNY N/A
- HASI 2013
- Fundamental
- Price
- SNY $48.55
- HASI $26.99
- Analyst Decision
- SNY Buy
- HASI Strong Buy
- Analyst Count
- SNY 2
- HASI 9
- Target Price
- SNY $62.50
- HASI $38.33
- AVG Volume (30 Days)
- SNY 2.2M
- HASI 1.7M
- Earning Date
- SNY 07-31-2025
- HASI 07-31-2025
- Dividend Yield
- SNY 3.29%
- HASI 6.21%
- EPS Growth
- SNY 39.56
- HASI N/A
- EPS
- SNY 5.45
- HASI 1.08
- Revenue
- SNY $48,817,552,946.00
- HASI $126,702,000.00
- Revenue This Year
- SNY $3.39
- HASI $189.49
- Revenue Next Year
- SNY $7.05
- HASI $14.03
- P/E Ratio
- SNY $8.90
- HASI $25.06
- Revenue Growth
- SNY N/A
- HASI N/A
- 52 Week Low
- SNY $45.80
- HASI $21.98
- 52 Week High
- SNY $60.12
- HASI $36.56
- Technical
- Relative Strength Index (RSI)
- SNY 45.89
- HASI 54.56
- Support Level
- SNY $48.39
- HASI $26.36
- Resistance Level
- SNY $49.43
- HASI $27.92
- Average True Range (ATR)
- SNY 0.56
- HASI 0.81
- MACD
- SNY 0.16
- HASI 0.03
- Stochastic Oscillator
- SNY 52.94
- HASI 63.64
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing about 30% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
About HASI Hannon Armstrong Sustainable Infrastructure Capital Inc.
HA Sustainable Infrastructure Capital Inc is an investor in sustainable infrastructure assets advancing the energy transition. Its investment is focused on actively partnering with clients to deploy capital in income-generating real assets that are supported by long-term recurring cash flows. This enabled to the generation of attractive risk-adjusted returns and provided stockholders with diversified exposure to the energy transition.